According to a new market research report published by sheer analytics and insights, “The Global Vaginitis Treatment Drugs Market was $5.1 Bn in 2020, and it is highly expected to reach $9.8 Bn by 2030. It is eventually growing at a commendable high compound of the annual growth rate CAGR of 6.7% between 2020 – 2030, as per the latest market research report Titled Global Vaginitis Treatment Drugs Market (By Drug Type- Nitro Imidazole Compounds, Lincosamide Antibiotics, Triazoles, Imidazoles. By Indication – Bacterial Vaginitis, Fungal Vaginitis (Yeast Infection), Trichomoniasis. Route of Administration – Oral, Cutaneous, Vaginal. By Schedule of Drug – Prescription Drugs (Rx), Over-the-Counter Drugs (OTC). By Distribution Channel – Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies. By Geography – North America, Latin America, Europe, Middle East and Africa.) – Global industry analysis, size, share, growth, trends and forecast, 2020 – 2030.
Download Free PDF Sample Request: https://www.sheeranalyticsandinsights.com/request-sample/vaginitis-treatment-drugs-market-21
It is seen that the vaginal infections plague two-fifths of the women population all over the world. Vaginitis in turn can lead to some serious complication and even risks like HIV-AIDS, miscarriage, pre-mature births if these are left untreated. Some other diseases like gonorrhea, chlamydia, papillomavirus are also known to carry some potential complications. But the main problem about detecting the vaginitis is that the majority of the patients are asymptomatic and here arises the difficulty od prescribing the appropriate medications. This market is said to have positive growth because the manufacturers are now concentrating to introduce the non-antibiotic drugs as a long term treatment solution for this infection. The players are also trying to introduce the single-dose and the over-the-counter drugs that will offer cost effective treatment. By schedule the prescriptiojn drugs dominate the Vaginitis Treatment Drugs Market.
Geographically, the Global Vaginitis Treatment Drugs Market is divided into global regions like North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The primary key players in the Global Vaginitis Treatment Drugs Market include Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Mylan N.V., Novartis International AG, Bayer AG, Sanofi S.A., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Sun Pharmaceutical Industries Limited.
Browse the full report at https://www.sheeranalyticsandinsights.com/market-report-research/vaginitis-treatment-drugs-market-21
The Vaginitis Treatment Drugs Market Has Been Segmented Into:
GLOBAL VAGINITIS TREATMENT DRUGS MARKET, BY DRUG TYPE
- Nitro Imidazole Compounds
- Lincosamide Antibiotics
GLOBAL VAGINITIS TREATMENT DRUGS MARKET, BY INDICATION
- Bacterial vaginitis
- Fungal vaginitis (yeast infection)
GLOBAL VAGINITIS TREATMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION
GLOBAL VAGINITIS TREATMENT DRUGS MARKET, BY SCHEDULE OF DRUG
- Prescription Drugs (Rx)
- Over-the-Counter Drugs (OTC)
GLOBAL VAGINITIS TREATMENT DRUGS MARKET, BY DISTRIBUTION CHANNEL
- Hospital pharmacies
- Retail pharmacies
- Drug stores
- Mail order pharmacies
GLOBAL VAGINITIS TREATMENT DRUGS MARKET, BY REGION
• North America (U.S., Canada)
• Europe (U.K., Germany, France, Spain, Italy, Rest of Europe)
• Asia Pacific (Japan, China, India, Rest of Asia Pacific)
• Rest of the World (Latin America, Middle East & Africa)